ANI Pharma

ANIP

----

Current ValuationThe current P/E ratio is 16.13, within the reasonable range, cheaper than 65.6% of the time in the past 3 years, and the industry ranks 29/255, the industry Median -1.30.

16.13xP/E

Stock price$71.52Earnings per share$4.43

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0285684112

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x20x40x60x80x100x

P/E ratio
Name/Symbol
BMYUSBristol Myers Squibb	13.11x	62.25%	$121.73B
GSKUSGSK	14.73x	16.02%	$94.96B
UCBJYUSUCB S.A.	16.99x	--	$43.28B
HLNUSHaleon	18.01x	1.74%	$39.07B
OTSKYUSOtsuka Pharmaceutical	14.71x	--	$38.08B
DSNKYUSDaiichi Sankyo	18.92x	--	$31.77B
ZTSUSZoetis	11.18x	6.76%	$29.48B
ALPMYUSAstellas Pharma	10.88x	--	$25.37B
JAZZUSJazz Pharma	15.97x	322.05%	$15.02B
OPHLYUSOno Pharmaceutical	13.75x	--	$6.70B
INDVUSIndivior Pharmaceuticals	11.90x	126.83%	$4.24B
HYPMYUSHypera S.A.	11.47x	--	$3.77B
OGNUSOrganon	17.26x	211.11%	$3.61B
SNPHYUSSanten Pharmaceutical	13.30x	--	$3.29B
LQDAUSLiquidia Tech	16.73x	410.63%	$2.32B
HRMYUSHarmony Biosciences	12.65x	45.48%	$2.29B
PBHUSPrestige Brands	12.79x	7.48%	$2.20B
ANIPUSANI Pharma	16.13x	51.20%	$1.61B
GTBIFUSGreen Thumb Industries Inc.	12.12x	--	$1.54B
PAHCUSPhibro Animal Health	14.91x	26.75%	$1.49B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.